COMPOSITION PHARMACEUTIQUE CONTENANT UN INHIBITEUR SGLT2 EN COMBINAISON AVEC UN INHIBITEUR DPP-IV ET OPTIOENELLEMENT UN AUTRE AGENT ANTIDIABETIQUE

• 收藏
• 分享

专利权人:

Boehringer Ingelheim International GmbH

发明人:

申请号：

EP10703288.0

公开号：

EP2395983B1

申请日:

2010.02.11

申请国别(地区):

EP

年份:

2020

代理人:

摘要：

The invention relates to a pharmaceutical composition according to the claim 1 comprising an SGLT2 inhibitor, a DPPIV inhibitor and a third antidiabetic agent which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/